GB201810668D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- GB201810668D0 GB201810668D0 GBGB1810668.2A GB201810668A GB201810668D0 GB 201810668 D0 GB201810668 D0 GB 201810668D0 GB 201810668 A GB201810668 A GB 201810668A GB 201810668 D0 GB201810668 D0 GB 201810668D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810668.2A GB201810668D0 (en) | 2018-06-28 | 2018-06-28 | New compounds |
| CA3104237A CA3104237A1 (en) | 2018-06-28 | 2019-06-28 | 4-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptors |
| EP19739692.2A EP3814335B1 (en) | 2018-06-28 | 2019-06-28 | 4-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptors |
| KR1020217000575A KR20210024531A (ko) | 2018-06-28 | 2019-06-28 | Trk 수용체의 조절제로서의 4-치환된 페닐-1,3,5-트리아진 유도체 |
| BR112020026619-1A BR112020026619A2 (pt) | 2018-06-28 | 2019-06-28 | Composto, método para tratar e/ou prevenir uma doença que apresenta sinalização prejudicada de neurotrofinas e/ou outros fatores trópicos, uso de um composto, produto de combinação, kit de partes, e, processo para a preparação de um composto |
| JP2020570716A JP7510358B2 (ja) | 2018-06-28 | 2019-06-28 | Trk受容体の調節剤としての4-置換フェニル-1,3,5-トリアジン誘導体 |
| ES19739692T ES2935183T3 (es) | 2018-06-28 | 2019-06-28 | Derivados de fenil-1,3,5-triazina 4-sustituidos como moduladores de los receptores TRK |
| PCT/GB2019/051853 WO2020002950A1 (en) | 2018-06-28 | 2019-06-28 | 4-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptors |
| CN201980045116.8A CN112513032B (zh) | 2018-06-28 | 2019-06-28 | 作为trk受体的调节剂的4-取代的苯基-1,3,5-三嗪衍生物 |
| US17/255,642 US11840524B2 (en) | 2018-06-28 | 2019-06-28 | 4-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810668.2A GB201810668D0 (en) | 2018-06-28 | 2018-06-28 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201810668D0 true GB201810668D0 (en) | 2018-08-15 |
Family
ID=63143731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1810668.2A Ceased GB201810668D0 (en) | 2018-06-28 | 2018-06-28 | New compounds |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11840524B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3814335B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7510358B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210024531A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112513032B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020026619A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3104237A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2935183T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201810668D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020002950A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11352332B2 (en) | 2018-02-26 | 2022-06-07 | AlzeCure Pharma AB | Triazine derivatives for treating diseases relating to neurotrophins |
| GB201912404D0 (en) * | 2019-08-29 | 2019-10-16 | AlzeCure Pharma AB | New compounds |
| US20240124406A1 (en) * | 2020-06-03 | 2024-04-18 | Dana-Farber Cancer Institute, Inc. | Inhibitors of transcriptional enhanced associate domain (tead) and uses thereof |
| WO2025232990A1 (en) | 2024-05-09 | 2025-11-13 | AlzeCure Pharma AB | Triazinone derivatives for use in the treatment of inflammation |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2246109A1 (de) | 1972-09-20 | 1974-03-28 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2313721A1 (de) | 1973-03-20 | 1974-10-03 | Bayer Ag | Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel |
| DE2413722C3 (de) | 1974-03-21 | 1982-04-08 | Bayer Ag, 5090 Leverkusen | Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel |
| DE2718799A1 (de) | 1977-04-27 | 1978-11-09 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer |
| EP0081142B1 (de) | 1981-12-03 | 1986-06-25 | BASF Aktiengesellschaft | 1,3,5-Triazinone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses |
| DE3314739A1 (de) | 1983-04-23 | 1984-10-25 | Bayer Ag, 5090 Leverkusen | 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel |
| DE3408768A1 (de) | 1984-03-09 | 1985-09-12 | Bayer Ag, 5090 Leverkusen | Immunstimulierende mittel |
| DE3516632A1 (de) | 1985-05-09 | 1986-11-13 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 1,3,5-triazintrionen |
| DE3516631A1 (de) | 1985-05-09 | 1986-11-13 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 3-methyl-1,3,5-triazintrionen |
| DE3703105A1 (de) | 1987-02-03 | 1988-08-11 | Bayer Ag | Mittel gegen protozoen bei insekten |
| DE3810080A1 (de) | 1988-03-25 | 1989-10-05 | Bayer Ag | Trisubstituierte 1,3,5-triazin-2,4,6-trione |
| DE3814323A1 (de) | 1988-04-28 | 1989-11-09 | Hoechst Ag | Wasserloesliche zubereitungen von coccidiostatica |
| US4933341A (en) | 1988-10-08 | 1990-06-12 | Bayer Aktiengesellschaft | Substituted 1,3,5-triazinetriones, for use against parasitic protozoa |
| DE4000624A1 (de) | 1990-01-11 | 1991-07-18 | Bayer Ag | Fungizide verwendung von trisubstituierten 1,3,5-triazin-2,4,6-trionen, neue trisubstituierte 1,3,5-triazin-2,4,6-trione und verfahren zu ihrer herstellung |
| DE4329096A1 (de) | 1993-08-30 | 1995-03-02 | Bayer Ag | Heterocyclylbenzoheterocyclen |
| US5519133A (en) | 1995-06-02 | 1996-05-21 | American Cyanamid Co. | 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
| CZ146296A3 (en) | 1995-06-02 | 1997-04-16 | American Cyanamid Co | 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents |
| US5604180A (en) | 1995-06-02 | 1997-02-18 | Crews, Jr.; Alvin D. | 3-(3-aryloxyphenyl)-1 (substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
| US5726126A (en) | 1995-06-02 | 1998-03-10 | American Cyanamid Company | 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents |
| US5679791A (en) | 1996-07-25 | 1997-10-21 | American Cyanamid Company | 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents |
| HK1043019B (zh) | 1998-10-08 | 2005-05-13 | 高新研究公司 | 用於预防和治疗原虫病的组合物和方法 |
| HUP0104716A3 (en) | 1998-12-22 | 2003-10-28 | Bayer Corp Pittsburgh | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them |
| DE19937500A1 (de) | 1999-08-09 | 2001-02-15 | Bayer Ag | Substituierte Heterocyclylbenzofurane |
| DE19958388A1 (de) | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten |
| US6444615B1 (en) | 2000-04-18 | 2002-09-03 | Dow Agrosciences Llc | Herbicidal imidazolidinetrione and thioxo-imidazolidinediones |
| DE10034800A1 (de) | 2000-07-18 | 2002-01-31 | Bayer Ag | Substituierte Benzostickstoffheterocyclen |
| DE10040174A1 (de) | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
| DE10040110A1 (de) | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen |
| AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| US6861523B2 (en) | 2002-02-08 | 2005-03-01 | Torrey Pines Institute For Molecular Studies | 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries |
| BR0304925A (pt) | 2002-05-30 | 2004-09-28 | Solvay Pharm Bv | Compostos, composições farmacêuticas, e, uso dos compostos |
| AU2003251010A1 (en) | 2002-07-15 | 2004-02-02 | Janssen Pharmaceutica N.V. | 3-furanyl analogs of toxoflavine as kinase inhibitors |
| DE102006038292A1 (de) | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen |
| WO2008148008A1 (en) * | 2007-05-23 | 2008-12-04 | Emory University | High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity |
| US20120004310A1 (en) * | 2010-05-28 | 2012-01-05 | Longo Frank M | Non-peptide bdnf neurotrophin mimetics |
| US9828330B2 (en) * | 2013-03-15 | 2017-11-28 | Pharmatrophix, Inc. | Non-peptide BDNF neurotrophin mimetics |
| RU2016131875A (ru) | 2014-01-20 | 2018-02-26 | Ф. Хоффманн-Ля Рош Аг | Производные n-фениллактама, способные стимулировать нейрогенез, и их применение при лечении заболеваний нервной системы |
| CN117137048A (zh) | 2014-12-10 | 2023-12-01 | 马斯公司 | 风味组合物、包含该组合物的食品及增加食品鲜味味道强度的方法 |
| EP3558320A1 (en) | 2016-12-21 | 2019-10-30 | Alzecure Pharma AB | Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinases |
| US11352332B2 (en) | 2018-02-26 | 2022-06-07 | AlzeCure Pharma AB | Triazine derivatives for treating diseases relating to neurotrophins |
| GB201810669D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
| GB201912404D0 (en) | 2019-08-29 | 2019-10-16 | AlzeCure Pharma AB | New compounds |
-
2018
- 2018-06-28 GB GBGB1810668.2A patent/GB201810668D0/en not_active Ceased
-
2019
- 2019-06-28 CA CA3104237A patent/CA3104237A1/en active Pending
- 2019-06-28 US US17/255,642 patent/US11840524B2/en active Active
- 2019-06-28 KR KR1020217000575A patent/KR20210024531A/ko active Pending
- 2019-06-28 CN CN201980045116.8A patent/CN112513032B/zh active Active
- 2019-06-28 JP JP2020570716A patent/JP7510358B2/ja active Active
- 2019-06-28 ES ES19739692T patent/ES2935183T3/es active Active
- 2019-06-28 WO PCT/GB2019/051853 patent/WO2020002950A1/en not_active Ceased
- 2019-06-28 EP EP19739692.2A patent/EP3814335B1/en active Active
- 2019-06-28 BR BR112020026619-1A patent/BR112020026619A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210024531A (ko) | 2021-03-05 |
| CN112513032A (zh) | 2021-03-16 |
| CA3104237A1 (en) | 2020-01-02 |
| EP3814335B1 (en) | 2022-11-09 |
| CN112513032B (zh) | 2024-07-02 |
| JP7510358B2 (ja) | 2024-07-03 |
| WO2020002950A1 (en) | 2020-01-02 |
| ES2935183T3 (es) | 2023-03-02 |
| US20210371402A1 (en) | 2021-12-02 |
| JP2021529168A (ja) | 2021-10-28 |
| EP3814335A1 (en) | 2021-05-05 |
| US11840524B2 (en) | 2023-12-12 |
| BR112020026619A2 (pt) | 2021-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3810602T (pt) | Compostos | |
| GB2583882B (en) | Compounds | |
| GB201805174D0 (en) | Compounds | |
| GB201807924D0 (en) | Compounds | |
| GB201810581D0 (en) | Compounds | |
| GB201808093D0 (en) | Compounds | |
| IL279620A (en) | compounds | |
| GB201812382D0 (en) | Compounds | |
| GB201811169D0 (en) | New compounds | |
| GB201814151D0 (en) | Compounds | |
| IL281440A (en) | Diaminotriazine compounds | |
| GB201809102D0 (en) | Compounds | |
| GB201817083D0 (en) | Compounds | |
| GB201810669D0 (en) | New compounds | |
| GB201810071D0 (en) | Compounds | |
| GB201803340D0 (en) | Compounds | |
| GB201801130D0 (en) | Compounds | |
| GB201801128D0 (en) | Compounds | |
| GB201817634D0 (en) | New compounds | |
| GB201813681D0 (en) | New compounds | |
| GB201819102D0 (en) | Compounds | |
| GB201805945D0 (en) | New compounds | |
| GB201804745D0 (en) | New compounds | |
| GB201816665D0 (en) | Compounds | |
| GB201802081D0 (en) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application |
Owner name: ALZECURE PHARMA AB Free format text: FORMER OWNER: STIFTELSEN ALZECURE |
|
| AT | Applications terminated before publication under section 16(1) |